{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:19:22Z","timestamp":1780471162032,"version":"3.54.1"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:00:00Z","timestamp":1550102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00214","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T04:34:48Z","timestamp":1550118888000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["B Cells as a Therapeutic Target in Paediatric Rheumatic Disease"],"prefix":"10.3389","volume":"10","author":[{"given":"Meredyth G. Ll","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cyto.2015.02.00","article-title":"B cells responses and cytokine production are regulated by their immune microenvironment","volume":"74","author":"Vazquez","year":"2015","journal-title":"Cytokine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-540-93864-4_7","article-title":"Visualizing the molecular and cellular events underlying the initiation of B-cell activation","volume":"334","author":"Harwood","year":"2009","journal-title":"Curr Top Microbiol Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: modulators of CD4+ T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1146\/annurev-immunol-020711-074934","article-title":"Immune regulatory function of B cells","volume":"30","author":"Mauri","year":"2012","journal-title":"Ann Rev Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2249.1998.00529.x","article-title":"B cell-deficient mice do not develop type II collagen-induced arthritis (CIA)","volume":"111","author":"Svensson","year":"1998","journal-title":"Clin Exp Immunol."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.8.5109","article-title":"Expression of CD80\/86 on B cells is essential for autoreactive T cell activation and the development of arthritis","author":"O'Neill","year":"2007","journal-title":"J Immunol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/ar3736","article-title":"Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis","author":"Carter","year":"2012","journal-title":"Arthr Res Therapy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nri1780","article-title":"Microenvironmental niches in the bone marrow required for B-cell development","volume":"6","author":"Nagasawa","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nri1225","article-title":"Regulating antigen-receptor gene assembly","volume":"3","author":"Schlissel","year":"2003","journal-title":"Nat Rev Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05877.x","article-title":"B cell receptor editing in tolerance and autoimmunity","volume":"1217","author":"Luning","year":"2011","journal-title":"Ann NY Acad Sci."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007146","article-title":"Central B-cell tolerance: where selection begins","author":"Pelanda","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","article-title":"Peripheral development of B cells in mouse and man","volume":"197","author":"Carsetti","year":"2004","journal-title":"Immunol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.coi.2008.03.003","article-title":"Cytokine-producing B lymphocytes-key regulators of immunity","volume":"20","author":"Lund","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nri3804","article-title":"Dynamics of B cells in germinal centres","volume":"15","author":"De","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002418","article-title":"Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus","author":"Andraud","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/s41467-017-01901-w","article-title":"Plasma cell survival in the absence of B cell memory","volume":"8","author":"Hammarlund","year":"2017","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"B22","first-page":"789","article-title":"Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis","volume":"33","author":"Wallace","year":"2006","journal-title":"J Rheumatol."},{"key":"B23","article-title":"Remission in juvenile idiopathic arthritis","author":"Ravelli","year":"2006","journal-title":"Clin Exp Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1759720X11413630","article-title":"Juvenile idiopathic arthritis: management and therapeutic options","volume":"4","author":"Ruth","year":"2012","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B25","first-page":"252","article-title":"Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis","volume":"22","author":"Dekker","year":"2004","journal-title":"Clin Exp Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3899\/jrheum.120583","article-title":"Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry","volume":"40","author":"Zannin","year":"2013","journal-title":"J Rheumatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/art.23291","article-title":"Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers","volume":"58","author":"Nistala","year":"2008","journal-title":"Arthritis Rheumat."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.40731.","article-title":"Innate Lymphoid Cells and T Cells Contribute to the Interleukin-17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis","author":"Rosser","year":"2018","journal-title":"Arthritis & Rheumatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"759868","DOI":"10.1155\/2010\/759868","article-title":"B-cell pathology in juvenile idiopathic arthritis","volume":"2010","author":"Wiegering","year":"2010","journal-title":"Arthritis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","article-title":"Juvenile idiopathic arthritis: diagnosis and treatment","volume":"3","author":"Giancane","year":"2016","journal-title":"Rheumatol Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrrheum.2009.209","article-title":"Oligoarticular and polyarticular JIA: epidemiology and pathogenesis","volume":"5","author":"Macaubas","year":"2009","journal-title":"Nat Rev Rheumatol."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000417","article-title":"Growing up with chronic arthritis: the confusing matter of classification","author":"Guillaume-Czitrom","year":"2017","journal-title":"RMD Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/rheumatology\/kel225","volume":"46","author":"Gregorio","year":"2007","journal-title":"Rheumatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/art.40443","article-title":"Brief report: the genetic profile of rheumatoid factor-positive polyarticular juvenile idiopathic arthritis resembles that of adult rheumatoid arthritis","volume":"70","author":"Hinks","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/art.40117","volume":"69","author":"Peckham","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ard.2009.122739","volume":"69","author":"Miriovsky","year":"2010","journal-title":"Ann Rheumat Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/ar2903","article-title":"The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis","volume":"12","author":"Pruijn","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B38","first-page":"239","article-title":"Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis","volume":"20","author":"Wouters","year":"2002","journal-title":"Clin Exp Rheumatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.4049\/jimmunol.0803391","article-title":"Identification and characterization of a human CD5+ pre-naive B cell population","volume":"182","author":"Lee","year":"2009","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.1016\/0008-8749(92)90111-2","article-title":"Analysis of the expression of CD5 by human B cells and correlation with functional activity","author":"Vernino","year":"1992","journal-title":"Cell Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1186\/ar2824","author":"Corcione","year":"2009","journal-title":"Arthritis Res Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","article-title":"Identification and characterization of circulating human transitional B cells","volume":"105","author":"Sims","year":"2005","journal-title":"Blood"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1136\/ard.2005.047878","article-title":"Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis","volume":"65","author":"Faber","year":"2006","journal-title":"Ann Rheumat Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-3083.2006.01859.x","article-title":"Abnormal kappa:lambda light chain ratio in circulating immune complexes as a marker for B cell activity in juvenile idiopathic arthritis","volume":"65","author":"Low","year":"2007","journal-title":"Scand J Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.immuni.2016.02.012","article-title":"A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus","volume":"44","author":"Menon","year":"2016","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12969-018-0262-9","article-title":"Frequency of CD19(+)CD24(hi)CD38(hi) regulatory B cells is decreased in peripheral blood and synovial fluid of patients with juvenile idiopathic arthritis: a preliminary study","volume":"16","author":"Zhao","year":"2018","journal-title":"Pediatric Rheumatol Online J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1002\/art.30569","volume":"63","author":"Morbach","year":"2011","journal-title":"Arthritis Rheumat."},{"key":"B48","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/art.40410","volume":"70","author":"Marasco","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B49","first-page":"161","article-title":"Systemic lupus erythematosus in the pediatric North American native population of British Columbia","volume":"33","author":"Houghton","year":"2006","journal-title":"J Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1177\/0961203307079562","article-title":"Lupus in adolescence","volume":"16","author":"Kone-Paut","year":"2007","journal-title":"Lupus"},{"key":"B51","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1191\/096120399678847786","article-title":"Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus","volume":"8","author":"Carre\u00f1o","year":"1999","journal-title":"Lupus"},{"key":"B52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3399\/bjgp18X694805","article-title":"The management of lupus in young people","volume":"68","author":"McGill","year":"2018","journal-title":"Br J Gen Pract"},{"key":"B53","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pcl.2012.03.007","article-title":"Systemic lupus erythematosus in children and adolescents","volume":"59","author":"Levy","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"B54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrrheum.2013.184","article-title":"Autoantibodies and SLE: the threshold for disease","volume":"10","author":"Olsen","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fimmu.2015.00228","article-title":"Mechanisms of autoantibody production in systemic lupus erythematosus","volume":"6","author":"Han","year":"2015","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1586\/eci.09.29","article-title":"Childhood- and adult-onset lupus: an update of similarities and differences","author":"Papadimitraki","year":"2009","journal-title":"Expert Rev Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/0961203316644333","volume":"25","author":"Ambrose","year":"2016","journal-title":"Lupus"},{"key":"B59","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1177\/0961203314563817","volume":"24","author":"Tarr","year":"2015","journal-title":"Lupus"},{"key":"B60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ng.81","article-title":"International Consortium for Systemic Lupus Erythematosus G, Harley JB, Alarcon-Riquelme ME, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci","volume":"40","author":"Harley","year":"2008","journal-title":"Nat Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/08916930701510848","article-title":"PTPN22: its role in SLE and autoimmunity","volume":"40","author":"Chung","year":"2007","journal-title":"Autoimmunity"},{"key":"B62","doi-asserted-by":"publisher","first-page":"eaap8855","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s12026-012-8365-8","article-title":"TLR7 drives accumulation of ABCs and autoantibody production in autoimmune-prone mice","volume":"55","author":"Rubtsov","year":"2013","journal-title":"Immunol Res"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol Sin"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1002\/art.22197","volume":"54","author":"Papadimitraki","year":"2006","journal-title":"Arthritis Rheumat."},{"key":"B66","doi-asserted-by":"publisher","first-page":"96795","DOI":"10.1172\/jci.insight.96795","article-title":"Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus","volume":"3","author":"Gies","year":"2018","journal-title":"JCI Insight"},{"key":"B67","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/rheumatology\/ker400","article-title":"Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE","volume":"51","author":"Midgley","year":"2012","journal-title":"Rheumatology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1002\/art.24902","volume":"60","author":"Hong","year":"2009","journal-title":"Arthritis Rheumat."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-12-S1-P321","article-title":"B lymphocyte stimulator, interferon-\u03b1 and HMGB 1 interrelation in childhood onset systemic lupus erythematosus: associations with disease activity and severity","author":"Kanakoudi-Tsakalidou","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.4049\/jimmunol.1500792","article-title":"B Cell-Specific MHC Class II Deletion reveals multiple nonredundant roles for B cell antigen presentation in murine lupus","volume":"195","author":"Giles","year":"2015","journal-title":"J Immunol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1546-0096-12-4","article-title":"The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus","volume":"12","author":"Ballantine","year":"2014","journal-title":"Pediatr Rheumatol Online J."},{"key":"B72","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/art.40418","volume":"70","author":"Deakin","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1186\/ar2987","article-title":"Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan","author":"Chen","year":"2010","journal-title":"Arthritis Res Therapy"},{"key":"B74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/B978-0-323-24145-8.00026-0","article-title":"Juvenile dermatomyositis","volume-title":"Textbook of Pediatric Rheumatology. 7th ed","author":"Rider","year":"2016"},{"key":"B75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"Shah","year":"2013","journal-title":"Medicine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.bor.0000434674.62644.02","article-title":"Update in juvenile myositis","volume":"25","author":"Nistala","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","article-title":"Muscle biopsy in combination with myositis-specific autoantibodies aids prediction of outcomes in juvenile dermatomyositis","volume":"11","author":"Deakin","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2017.06.007","article-title":"Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort","volume":"84","author":"Tansley","year":"2017","journal-title":"J Autoimmun."},{"key":"B79","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410160206","article-title":"Monoclonal antibody analysis of mononuclear cells in myopathies. I: quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells","volume":"16","author":"Arahata","year":"1984","journal-title":"Ann Neurol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1089\/jir.2011.0092","article-title":"Intracellular nucleic acid sensors and autoimmunity","volume":"31","author":"Theofilopoulos","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B82","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1002\/art.22928","volume":"56","author":"Walsh","year":"2007","journal-title":"Arthritis Rheum."},{"key":"B83","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ana.20464","article-title":"Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis","volume":"57","author":"Greenberg","year":"2005","journal-title":"Ann Neurol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fimmu.2018.01372","article-title":"CD19(+)CD24(hi)CD38(hi) B cells are expanded in juvenile dermatomyositis and exhibit a pro-inflammatory phenotype after activation through toll-like receptor 7 and Interferon-alpha","volume":"9","author":"Piper","year":"2018","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"Martin","year":"2011","journal-title":"Rheumatology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/BOR.0000000000000119","article-title":"Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research","volume":"26","author":"Rider","year":"2014","journal-title":"Curr Opin Rheumatol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/art.39820","article-title":"The regulatory B cell compartment expands transiently during childhood and is contracted in children with autoimmunity","volume":"69","author":"Kalampokis","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1136\/annrheumdis-2015-208119","article-title":"Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups","volume":"75","author":"Rothwell","year":"2016","journal-title":"Ann Rheumatic Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intimp.2008.10.004","article-title":"A review of the current use of rituximab in autoimmune diseases","volume":"9","author":"G\u00fcrcan","year":"2009","journal-title":"Int Immunopharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/art.34359","article-title":"Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis assessment with rituximab study","volume":"64","author":"Rovin","year":"2012","journal-title":"Arthritis Rheumatism"},{"key":"B92","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheumat."},{"key":"B93","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1002\/art.38439","article-title":"Favorable response to belimumab in pediatric-onset systemic lupus erythematosus","volume":"66","author":"Hui-Yuen","year":"2014","journal-title":"Arthritis & Rheumatology"},{"key":"B94","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/tcrm.2006.2.2.207","article-title":"Rituximab and its potential for the treatment of rheumatoid arthritis","volume":"2","author":"Bryant","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"B95","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/art.27233","article-title":"Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II\/III systemic lupus erythematosus evaluation of rituximab trial","volume":"62","author":"Merrill","year":"2010","journal-title":"Arthritis Rheumat."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1186\/ar3910","article-title":"B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design","author":"Reddy","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.4049\/jimmunol.1101629","article-title":"An acquired defect in IgG-dependent phagocytosis explains the impairment in antibody-mediated cellular depletion in Lupus","volume":"187","author":"Ahuja","year":"2011","journal-title":"J Immunol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1546-0096-12-13","article-title":"Treatment of juvenile idiopathic arthritis: a revolution in care","volume":"12","author":"Stoll","year":"2014","journal-title":"Pediatric Rheumatol Online J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.rbr.2014.12.015","article-title":"Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases","volume":"55","author":"Sakamoto","year":"2015","journal-title":"Rev Bras Reumatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"164","DOI":"10.5152\/eurjrheumatol.2014.140049","article-title":"A successful treatment of juvenile idiopathic arthritis with rituximab: A report of two cases","volume":"1","author":"Berrada","year":"2014","journal-title":"Eur J Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0961203314547793","article-title":"The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE","volume":"24","author":"Watson","year":"2015","journal-title":"Lupus"},{"key":"B102","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jpeds.2006.01.041","volume":"148","author":"Willems","year":"2006","journal-title":"J Pediatrics"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1002\/art.21351","volume":"52","author":"Marks","year":"2005","journal-title":"Arthritis Rheumat."},{"key":"B104","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12969-018-0278-1","article-title":"Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C delta","volume":"16","author":"Lei","year":"2018","journal-title":"Pediatric Rheumatol. Online J."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/rheumatology\/kev417","article-title":"Abatacept efficacy in rheumatoid arthritis is dependent upon baseline blood B-cell levels","volume":"55","author":"Gazeau","year":"2016","journal-title":"Rheumatology"},{"key":"B106","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12016-017-8603-x","article-title":"Memory B Cells and response to abatacept in rheumatoid arthritis","volume":"53","author":"Gazeau","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/art.38895","article-title":"Activation of Syk in peripheral blood B cells in patients with rheumatoid arthritis: a potential target for abatacept therapy","volume":"67","author":"Iwata","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3899\/jrheum.151389","article-title":"Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis","volume":"43","author":"Birolo","year":"2016","journal-title":"J Rheumatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"B111","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","article-title":"Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis","volume":"160","author":"Arabshahi","year":"2012","journal-title":"J Pediat."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T04:34:52Z","timestamp":1550118892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,14]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2019.00214"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00214","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,14]]},"article-number":"214"}}